BioPharmSignal logoBioPharmSignal

Biotech News

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

Integra LifeSciences (IART)Integra LifeSciencesEarnings

PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2026 financial results on Wednesday, October 21, 2026, prior to the market open. In conjunction with the earnings

Related news

IARTIntegra LifeSciences2026-07-29 10:00 EST

Integra LifeSciences Reports Second Quarter 2026 Financial Results

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

AEMDAethlon Medical2026-08-05 12:01 EST

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

MMSIMerit Medical2026-10-06 20:30 EST

Merit Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026

NEPHNephros2026-08-05 20:00 EST

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

XAIRBeyond Air2026-08-04 12:00 EST

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

IRMDiRadimed2026-07-24 20:15 EST

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

RMDResMed2026-10-01 20:05 EST

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

ANGOAngioDynamics2026-09-28 20:30 EST

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026

View all latest news

Integra LifeSciences

Medical Technology Portfolio Integra LifeSciences develops medical technologies used in neurosurgery, reconstructive surgery and wound care. Its products support procedures in which tissue protection, repair and regeneration are critical to patient outcomes. Neurosurgical Technologies The company supplies instruments, implants and...

Recent company news

IARTIntegra LifeSciences2026-10-06 12:30 EST

Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

IARTIntegra LifeSciences2026-10-02 12:00 EST

Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B

IARTIntegra LifeSciences2026-09-29 12:30 EST

Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

IARTIntegra LifeSciences2026-09-25 13:05 EST

Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026

Stock data

Close
13.32 USD
Market cap
1.22B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States